Cambridge Biotechnology Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Employees
  • 25
  • Latest Deal Type
  • M&A

Cambridge Biotechnology General Information


Developer of drugs for the treatment of clinical obesity. The company develops lead compounds for diseases with large medical needs using proprietary technologies.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Building 250
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambridge Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 21-Mar-2005 000.00 Completed Product Development
2. Early Stage VC 30-Sep-2004 00.000 000.00 Completed Product Development
1. Early Stage VC (Series A) 01-Jul-2002 $8.94M $8.94M Completed Product Development
To view Cambridge Biotechnology’s complete valuation and funding history, request access »

Cambridge Biotechnology Executive Team (2)

Name Title Board Seat Contact Info
Akshay Vaishnaw Ph.D Executive Vice President & Chief Medical Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Cambridge Biotechnology Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambridge Biotechnology Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avlar BioVentures Venture Capital Minority 000 0000 000000 0
Cambridge Gateway Fund Venture Capital Minority 000 0000 000000 0
Excalibur Group Holdings Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
NVM Private Equity PE/Buyout Minority 000 0000 000000 0
To view Cambridge Biotechnology’s complete investors history, request access »